16.63 USD
↗ 1.12 (7.22%)LIVE (AS OF 11:27 AM EDT)
Nurix Therapeutics, Inc. Common stock
NRIXNASDAQ • USD
Market: OPEN
Open?$15.78
High?$16.85
Low?$15.40
Prev. Close?$15.51
Volume?682.9K
Avg. Volume?1.2M
VWAP?$16.40
Rel. Volume?0.59x
Bid / Ask
Bid?$16.64 × 200
Ask?$16.69 × 100
Spread?$0.05
Midpoint?$16.67
Valuation & Ratios
Market Cap?1.6B
Shares Out?103.4M
Float?88.6M
Float %?86.2%
P/E Ratio?N/A
P/B Ratio?2.98
EPS?-$2.56
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?7.02Strong
Quick Ratio?7.02Strong
Cash Ratio?2.86Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?2.98CHEAP▾
P/S?19.10HIGH▾
P/FCF?N/A▾
EV/EBITDA?-4.9CHEAP▾
EV/Sales?16.16HIGH▾
Returns & Efficiency
ROE?-49.1%WEAK▾
ROA?-38.4%WEAK▾
Cash Flow & Enterprise
FCF?$-263467000
Enterprise Value?$1.4B
Related Companies
Loading...
News
Profile
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Address
1600 SIERRA POINT PKWY
BRISBANE, CA 94005
Phone: (415) 660-5320
BRISBANE, CA 94005
Phone: (415) 660-5320